Fred Hardwicke
- Dermatology top 5%
-
- Cancer Treatment and Pharmacology 12
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 3
-
- Multiple Myeloma Research and Treatments 6
-
- Chronic Lymphocytic Leukemia Research 4
-
- Immunotherapy and Immune Responses 3
-
- Advanced Breast Cancer Therapies 7
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Everardo CobosKenneth NugentAlejandro Perez‐VerdiaNicholas D’CunhaYuefei YuMaurizio Chiriva‐InternatiW. Martin KastMartin J. Cannon
- Cited by
- DermatologyOncologyHematology
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (2 papers)Blood (5 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Fred Hardwicke
32 papers receiving 368 citations
Peers
Comparison fields: 5 of 60
- Dermatology 119
- Oncology 222
- Hematology 56
- Genetics 47
- Immunology 45
Countries citing papers authored by Fred Hardwicke
This map shows the geographic impact of Fred Hardwicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Hardwicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Hardwicke more than expected).
Fields of papers citing papers by Fred Hardwicke
This network shows the impact of papers produced by Fred Hardwicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Hardwicke. The network helps show where Fred Hardwicke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fred Hardwicke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2020 | 0 | |
| 3 | 2020 | 1 | |
| 4 | 2019 | 0 | |
| 5 | 2019 | 23 | |
| 6 | 2019 | 5 | |
| 7 | 2019 | 3 | |
| 8 | 2018 | 0 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 1 | |
| 11 | 2015 | 25 | |
| 12 | 2014 | 3 | |
| 13 | 2012 | 2 | |
| 14 | 2011 | 40 | |
| 15 | 2008 | 14 | |
| 16 | AKAP-4 as biomarker for prostate cancer | 2008 | 0 |
| 17 | 2005 | 43 | |
| 18 | 2004 | 8 | |
| 19 | 2003 | 24 | |
| 20 | Non-Hodgkin's lymphoma occurring as pure central nervous system pathology. | 2003 | 2 |
About Fred Hardwicke
Fred Hardwicke is a scholar working on Oncology, Hematology and Genetics, having authored 36 papers that have together received 377 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (7 papers), Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), PARP inhibition in cancer therapy (4 papers), Immunotherapy and Immune Responses (3 papers), HER2/EGFR in Cancer Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Dermatology (119 citations), Oncology (222 citations) and Hematology (56 citations). Fred Hardwicke has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Everardo Cobos, Kenneth Nugent, Alejandro Perez‐Verdia, Nicholas D’Cunha, Yuefei Yu, Maurizio Chiriva‐Internati, W. Martin Kast, Martin J. Cannon, Somedeb Ball and Leonardo Mirandola. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.